Last updated: 2026-10-14 08:54:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Edwards Lifesciences Corp. (EW) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NYSE. The stock is currently priced at $85.90, with a market capitalization of $49.80B and a P/E ratio of 48.91. Over the past 52 weeks, its price has ranged from $72.40 to $96.29. This page covers its latest market performance, valuation, price trends and company information.
$49.80B | |
$85.70 | |
$131.73 | |
$2.23 | |
$85.27 | |
15.00 | |
3.75M | |
48.91 | |
$96.29 | |
$72.40 | |
-- | |
-- |
Edwards Lifesciences Corp. (EW) is trading at $85.90 in pre-market trading as of 2026-10-14 08:47:00, up 0.74% ($0.63) from the previous close of $85.27
Pre-market trading shows how investors are pricing EW before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Edwards Lifesciences Corp. (EW) moved from $87.23 to $85.90, representing a decline of 1.53% ($1.33).
The stock traded between $82.43 and $87.88 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 3.94 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 56.5%
EW is currently trading at $85.90, placing it 56.5% of the way from its 52-week low of $72.40 to its 52-week high of $96.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 16000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Edwards Lifesciences Corp. (EW) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.